Novel therapeutic targets for multiple myeloma
Anuj Mahindra1, Diana Cirstea, Noopur Raje
1Massachusetts General Hospital, Boston, MA 02114, USA. amahindra@partners.org
Future Oncology (London, England)
|March 13, 2010
Summary
Despite advances, multiple myeloma (MM) remains incurable. Research focuses on novel therapeutic targets, including protein dynamics, signaling pathways, and immune responses, to improve patient outcomes.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Multiple myeloma (MM) treatment has significantly improved due to novel targeted agents.
- Despite progress, MM remains an incurable malignancy, necessitating ongoing research into its biology and therapeutic strategies.
Purpose of the Study:
- To review novel therapeutic targets in multiple myeloma with promising preclinical and early clinical data.
- To categorize emerging agents based on their molecular targets within the tumor and stromal compartments.
Main Methods:
- Literature review of novel therapeutic targets and agents in multiple myeloma.
- Categorization of agents targeting protein dynamics, signaling pathways, cell cycle, membrane receptors, epigenetics, tumor microenvironment, and immune responses.
Main Results:
- Several novel agents targeting diverse pathways show promising preclinical and early clinical anti-MM activity.
- Emerging therapies target key aspects of MM biology, including protein homeostasis, signaling cascades, cell proliferation, and immune evasion.
Conclusions:
- Continued investigation into novel therapeutic targets is crucial for advancing multiple myeloma treatment.
- Combination therapies involving novel agents hold potential for improving outcomes in patients with multiple myeloma.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...